Princeton Portfolio Strategies Group’s AstraZeneca AZN Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$620K	Hold	5,175	–	–	0.12%	112
2021 Q1	$515K	Buy	5,175 +458	+10%	+$46K	0.1%	122
2020 Q4	$472K	Hold	4,717	–	–	0.09%	125
2020 Q3	$517K	Hold	4,717	–	–	0.11%	117
2020 Q2	$499K	Hold	4,717	–	–	0.12%	112
2020 Q1	$421K	Sell	4,717 -108	-2%	-$10.2K	0.12%	108
2019 Q4	$481K	Hold	4,825	–	–	0.11%	115
2019 Q3	$430K	Hold	4,825	–	–	0.11%	114
2019 Q2	$398K	Hold	4,825	–	–	0.1%	118
2019 Q1	$390K	Hold	4,825	–	–	0.1%	122
2018 Q4	$367K	Sell	4,825 -3,763	-44%	-$294K	0.11%	120
2018 Q3	$680K	Hold	8,588	–	–	0.18%	107
2018 Q2	$603K	Sell	8,588 -5,150	-37%	-$371K	0.17%	109
2018 Q1	$961K	Hold	13,738	–	–	0.27%	92
2017 Q4	$953K	Hold	13,738	–	–	0.26%	95
2017 Q3	$931K	Buy	13,738 +1,150	+9%	+$72.7K	0.25%	97
2017 Q2	$858K	Hold	12,588	–	–	0.25%	92
2017 Q1	$784K	Buy	12,588 +75	+0.6%	+$4.37K	0.23%	95
2016 Q4	$684K	Hold	12,513	–	–	0.22%	94
2016 Q3	$822K	Buy	12,513 +150	+1%	+$9.8K	0.26%	86
2016 Q2	$746K	Buy	12,363 +420	+4%	+$24.4K	0.24%	93
2016 Q1	$673K	Sell	11,943 -270	-2%	-$16.2K	0.23%	95
2015 Q4	$829K	Buy	12,213 +150	+1%	+$9.83K	0.29%	77
2015 Q3	$768K	Buy	12,063 +3,863	+47%	+$254K	0.31%	74
2015 Q2	$522K	Buy	+8,200	New	+$561K	0.18%	92

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Princeton Portfolio Strategies Group's AZN Position: Q2 2021 in Review

Princeton Portfolio Strategies Group held its AstraZeneca (AZN) position steady in Q2 2021 at 5,175 shares worth $620K. The position accounts for 0.12% of the portfolio, ranked #112.

Princeton Portfolio Strategies Group first reported a position in AZN in Q2 2015 and has held it in 25 quarters since. The position peaked at $961K in Q1 2018. 769 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

Princeton Portfolio Strategies Group held 5,175 shares of AstraZeneca worth $620K as of Q2 2021.
Princeton Portfolio Strategies Group left its AstraZeneca share count unchanged in Q2 2021.
AstraZeneca made up 0.12% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #112 holding.
Princeton Portfolio Strategies Group first reported a position in AstraZeneca in Q2 2015 and has held it in 25 quarters since.
Princeton Portfolio Strategies Group's AstraZeneca position peaked at $961K in Q1 2018.
769 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.